SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-06-018325
Filing Date
2006-03-16
Accepted
2006-03-16 20:35:42
Documents
1
Period of Report
2006-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1523
  Complete submission text file 0001209191-06-018325.txt   3335
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 416 MARLBOROUGH STREET APT. 707 BOSTON MA 02115
Business Address 857-753-4093
Gillespie Deirdre (Reporting) CIK: 0001354737 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 06693761